SARS News and Research

RSS

REGEN-COV shown to reduce risk of COVID-19–related hospitalization or death from any cause

The phase 1-2 clinical trials conducted using REGEN-COV had shown promising therapeutic benefits in COVID-19 outpatients. Its effect was further investigated in the present phase 3 clinical trial, the findings of which have been published in the "The New England Journal of Medicine".

3 Oct 2021

Machine learning predicts hospital-onset COVID-19 infections using patient contact networks

Researchers from the UK recently developed a real-time machine learning framework that uses dynamic patient contact networks to predict hospital-onset COVID-19 infections (HOCIs) at the patient level. They then tested and validated the framework on international multi-site datasets across various epidemic and endemic periods. This study can be found on the medRxiv* preprint server.

3 Oct 2021

Immune response to SARS-CoV-2 variants of concern after natural infection or vaccination

A recent review paper published in the MDPI's journal Viruses highlights how available vaccines may be effective in protecting individuals against severe forms of coronavirus disease 2019 (COVID-19), but the protection against infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its transmission to others may be reduced – with consequences for community protection and herd immunity.

3 Oct 2021

Children are less likely to get long-COVID, yet still at risk, study finds

A new study investigates the persistence of neuropsychiatric symptoms in children and adolescents several months after they tested positive for SARS-CoV-2.

3 Oct 2021

SARS-CoV-2 infection and severity are strongly associated with nasal microbiota

In a recent study, researchers conducted a nasopharyngeal microbiota profiling parallelism in an effort to analyze microbiota variations in COVID-19 patients.

3 Oct 2021

Dispensing of hydroxychloroquine and ivermectin in Australia jumped in first year of COVID

A new study describes the nature and extent of the shift in dispensing these medications, as well as its eventual outcome.

3 Oct 2021

Non-pharmaceutical interventions effectively reduce COVID case burden in the United States

A new study analyzes the impact of non-pharmaceutical interventions in the United States against SARS-CoV-2 transmission.

3 Oct 2021

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

A recent study discusses the rate of changes in peripheral blood white cells in individuals who have recovered from SARS-CoV-2 infection.

3 Oct 2021

Important factors that determine the child clinical COVID-19 attack ratio

A new modeling study aimed to determine the attack ratio among children between the ages of 0-11 years in Ontario, Canada.

3 Oct 2021

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

2 Oct 2021

Cancer patients on chemotherapy have lower immune response to COVID-19 vaccine, study finds

The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed to defend the body from infections.

2 Oct 2021

CDC awards $15.88 million to Wayne State University to study viral infection surveillance

The U.S. Centers for Disease Control and Prevention has awarded $15.88 million to the Wayne State University School of Medicine's Department of Emergency Medicine to be the epicenter of a national study on viral infections that present in emergency departments across the county.

1 Oct 2021

SARS News and Research

REGEN-COV shown to reduce risk of COVID-19–related hospitalization or death from any cause

Machine learning predicts hospital-onset COVID-19 infections using patient contact networks

Immune response to SARS-CoV-2 variants of concern after natural infection or vaccination

Children are less likely to get long-COVID, yet still at risk, study finds

SARS-CoV-2 infection and severity are strongly associated with nasal microbiota

Dispensing of hydroxychloroquine and ivermectin in Australia jumped in first year of COVID

Non-pharmaceutical interventions effectively reduce COVID case burden in the United States

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

Important factors that determine the child clinical COVID-19 attack ratio

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

Cancer patients on chemotherapy have lower immune response to COVID-19 vaccine, study finds

CDC awards $15.88 million to Wayne State University to study viral infection surveillance

Two-mAb cocktail prevents SARS-CoV-2 infection, study suggests

Enveloped virus-like particle based vaccines potentially broaden immunity against SARS-CoV-2 variants

Structure of monoclonal antibody that can potently neutralize SARS-CoV-2 and variants of concern

Persistence of humoral immune response in SARS-CoV-2 convalescent individuals a year after infection

Similar viral load in vaccinated and unvaccinated individuals infected with SARS-CoV-2 Delta variant

The extent to which COVID-19 vaccination reduces transmission varies with vaccine type and SARS-CoV-2 strain

Study finds US pediatric COVID-19 cases are higher than expected

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News